Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal

Chandni Hindocha*, Tom P. Freeman, Meryem Grabski, Jack B. Stroud, Holly Crudgington, Alan C. Davies, Ravi K. Das, William Lawn, Celia J.A. Morgan, H. Valerie Curran

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

71 Citations (Scopus)
324 Downloads (Pure)


Background and Aims: Cannabidiol (CBD), a non-intoxicating cannabinoid found in cannabis, may be a promising novel smoking cessation treatment due to its anxiolytic properties, minimal side effects and research showing that it may modify drug cue salience. We used an experimental medicine approach with dependent cigarette smokers to investigate if (1) overnight nicotine abstinence, compared with satiety, will produce greater attentional bias (AB), higher pleasantness ratings of cigarette-related stimuli and increased craving and withdrawal; and (2) CBD in comparison to placebo, would attenuate AB, pleasantness of cigarette-related stimuli, craving and withdrawal and not produce any side effects. Design: Randomized, double-blind cross-over study with a fixed satiated session followed by two overnight abstinent sessions. Setting: UK laboratory. Participants: Thirty non-treatment-seeking, dependent cigarette smokers recruited from the community. Intervention and comparator: 800 mg oral CBD, or matched placebo (PBO) in a counterbalanced order. Measurements: AB to pictorial tobacco cues was recorded using a visual probe task and an explicit rating task. Withdrawal, craving, side effects, heart rate and blood pressure were assessed repeatedly. Findings: When participants received PBO, tobacco abstinence increased AB (P = 0.001, d = 0.789) compared with satiety. However, CBD reversed this effect, such that automatic AB was directed away from cigarette cues (P = 0.007, d = 0.704) and no longer differed from satiety (P = 0.82). Compared with PBO, CBD also reduced explicit pleasantness of cigarette images (P = 0.011; d = 0.514). Craving (Bayes factor = 7.08) and withdrawal (Bayes factor = 6.95) were unaffected by CBD, but greater in abstinence compared with satiety. Systolic blood pressure decreased under CBD during abstinence. Conclusions: A single 800-mg oral dose of cannabidiol reduced the salience and pleasantness of cigarette cues, compared with placebo, after overnight cigarette abstinence in dependent smokers. Cannabidiol did not influence tobacco craving or withdrawal or any subjectively rated side effects.

Original languageEnglish
Pages (from-to)1696-1705
Number of pages10
Issue number9
Early online date3 Jun 2018
Publication statusPublished - 1 Sept 2018

Structured keywords

  • Tobacco and Alcohol


  • Abstinence
  • attentional bias
  • cannabidiol
  • cigarette dependence
  • craving
  • withdrawal


Dive into the research topics of 'Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal'. Together they form a unique fingerprint.

Cite this